451 related articles for article (PubMed ID: 28361246)
1. Multidrug-resistant Mycoplasma genitalium infections in Europe.
Braam JF; van Dommelen L; Henquet CJM; van de Bovenkamp JHB; Kusters JG
Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1565-1567. PubMed ID: 28361246
[TBL] [Abstract][Full Text] [Related]
2. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.
Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS
PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan.
Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H
J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106
[TBL] [Abstract][Full Text] [Related]
4. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.
Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T
J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419
[TBL] [Abstract][Full Text] [Related]
5. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.
Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L
BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173
[TBL] [Abstract][Full Text] [Related]
6. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.
Murray GL; Bradshaw CS; Bissessor M; Danielewski J; Garland SM; Jensen JS; Fairley CK; Tabrizi SN
Emerg Infect Dis; 2017 May; 23(5):809-812. PubMed ID: 28418319
[TBL] [Abstract][Full Text] [Related]
7. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL
Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013
[TBL] [Abstract][Full Text] [Related]
8. Detection of markers predictive of macrolide and fluoroquinolone resistance in
Pitt R; Fifer H; Woodford N; Alexander S
Sex Transm Infect; 2018 Feb; 94(1):9-13. PubMed ID: 28717051
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS
Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland.
Hokynar K; Hiltunen-Back E; Mannonen L; Puolakkainen M
Int J STD AIDS; 2018 Aug; 29(9):904-907. PubMed ID: 29631509
[TBL] [Abstract][Full Text] [Related]
11. Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016.
Unemo M; Salado-Rasmussen K; Hansen M; Olsen AO; Falk M; Golparian D; Aasterød M; Ringlander J; Nilsson CS; Sundqvist M; Schønning K; Moi H; Westh H; Jensen JS
Clin Microbiol Infect; 2018 May; 24(5):533-539. PubMed ID: 28923377
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.
Pond MJ; Nori AV; Witney AA; Lopeman RC; Butcher PD; Sadiq ST
Clin Infect Dis; 2014 Mar; 58(5):631-7. PubMed ID: 24280088
[TBL] [Abstract][Full Text] [Related]
13. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS
Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of
Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL
J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34590993
[No Abstract] [Full Text] [Related]
15. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan.
Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M
J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860
[TBL] [Abstract][Full Text] [Related]
16. Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin.
Guschin A; Ryzhikh P; Rumyantseva T; Gomberg M; Unemo M
BMC Infect Dis; 2015 Feb; 15():40. PubMed ID: 25645440
[TBL] [Abstract][Full Text] [Related]
17. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014.
Muller EE; Mahlangu MP; Lewis DA; Kularatne RS
BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
Jensen JS; Fernandes P; Unemo M
Antimicrob Agents Chemother; 2014 Jun; 58(6):3151-6. PubMed ID: 24637681
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of macrolide- and fluoroquinolone-resistant Mycoplasma genitalium strains in clinical specimens from men who have sex with men of two sexually transmitted infection practices in Berlin, Germany.
Dumke R; Ziegler T; Abbasi-Boroudjeni N; Rust M; Glaunsinger T
J Glob Antimicrob Resist; 2019 Sep; 18():118-121. PubMed ID: 31252154
[TBL] [Abstract][Full Text] [Related]
20. Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
Vodstrcil LA; Plummer EL; Doyle M; Murray GL; Bodiyabadu K; Jensen JS; Whiley D; Sweeney E; Williamson DA; Chow EPF; Fairley CK; Bradshaw CS
Clin Infect Dis; 2022 Sep; 75(5):813-823. PubMed ID: 34984438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
